Table 1 Demographics and characteristics of patients
From: A single-center, retrospective study of COVID-19 features in children: a descriptive investigation
Characteristics | Group A | Group B | Group A + B | Group C |
|---|---|---|---|---|
Age, years | 3.0 (0.9–7.5) | 1.0 (1.0–4.5) | 2.5 (0.9–7.0) | 2.5 (1.2–9.8) |
> 2.5 | 22/43 (51%) | 3/7 (43%) | 25/50 (50%) | 13/26 (50%) |
≤ 2.5 | 21/43 (49%) | 4/7 (57%) | 25/50 (50%) | 13/26 (50%) |
Sex | ||||
Male | 23/43 (53%) | 5/7 (71%) | 28/50 (56%) | 14/26 (54%) |
Female | 20/43 (47%) | 2/7 (29%) | 22/50 (44%) | 12/26 (46%) |
Type of care | ||||
Discharged patients | 33/43 (77%) | 5/7 (71%) | 38/50 (76%) | 26/26 (100%) |
Hospitalization duration | 11.0 (9.0~13.0) | 13.0 (7.0~14.0) | 11.0 (8.2~13.8) | 10.5 (8.0~12.0) |
Clinical status | ||||
Asymptomatica | 0/43 (0%) | 2/7 (29%) | 2/50 (4%) | 0/26 (0%) |
Very mild | 0/43 (0%) | 5/7 (71%) | 5/50 (10%) | 0/26 (0%) |
Mild | 41/43 (95%) | 0/7 (0%) | 41/50 (82%) | 26/26 (100%) |
Severe | 0/43 (0%) | 0/7 (0%) | 0/50 (0%) | 0/26 (0%) |
Critically ill | 2/43 (5%) | 0/7 (0%) | 2/50 (4%) | 0/26 (0%) |
Symptoms | ||||
Fever | 29/43 (67%) | 3/7 (43%) | 32/50 (64%) | 21/26 (81%) |
Cough | 21/43 (49%) | 1/7 (14%) | 22/50 (44%) | 19/26 (73%) |
Myalgia or fatigue | 2/43 (5%) | 0/7 (0%) | 2/50 (4%) | 0/26 (0%) |
Sore throat (pharyngalgia) | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
Diarrhea | 3/43 (7%) | 0/7 (0%) | 3/50 (6%) | 0/26 (0%) |
Abdominal pain | 2/43 (5%) | 0/7 (0%) | 2/50 (4%) | 0/26 (0%) |
Rhinorrhea | 7/43 (16%) | 1/7 (14%) | 8/50 (16%) | 2/26 (8%) |
Loss of appetite | 2/43 (5%) | 0/7 (0%) | 2/50 (4%) | 0/26 (0%) |
Chest pain | 0/43 (0%) | 0/7 (0%) | 0/50(0%) | 1/26 (4%) |
Intussusception | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
No symptoms | 4/43 (9%) | 2/7 (29%) | 6/50 (12%) | 0/26 (0%) |
Mortality | 0/43 (0%) | 0/7 (0%) | 0/50 (0%) | 0/26 (0%) |
Comorbidity | ||||
Cardiac damage | 4/43 (9%) | 1/7 (14%) | 5/50 (10%) | 3/26 (12%) |
Appendicitis | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
Foreign body in bronchus | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
Mycoplasma infection | 5/43 (12%) | 0/7 (0%) | 5/50 (10%) | 11/26 (42%) |
Respiratory syncytial virus infection | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
Renal failure | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
Intestinal necrosis in MODS | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |